- Home
- WALD vs FATE Comparison
WALD vs FATE Comparison
Compare WALD & FATE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | WALD | FATE |
|---|---|---|
| Founded | 1988 | 2007 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Package Goods/Cosmetics | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 111.9M | 125.6M |
| IPO Year | 2021 | 2013 |
Fundamental Metrics
Financial Performance| Metric | WALD | FATE |
|---|---|---|
| Price | $0.88 | $2.18 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 11 |
| Target Price | $2.05 | ★ $5.74 |
| AVG Volume (30 Days) | 387.4K | ★ 1.6M |
| Earning Date | 09-28-2026 | 11-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 29.88 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $6,646,000.00 |
| Revenue This Year | $5.33 | N/A |
| Revenue Next Year | $10.82 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.72 | $0.95 |
| 52 Week High | $3.22 | $3.23 |
Technical Indicators
Market Signals| Indicator | WALD | FATE |
|---|---|---|
| Relative Strength Index (RSI) | 27.05 | 39.15 |
| Support Level | $0.86 | $1.06 |
| Resistance Level | $1.85 | $2.62 |
| Average True Range (ATR) | 0.10 | 0.15 |
| MACD | -0.02 | -0.02 |
| Stochastic Oscillator | 16.50 | 25.83 |
Price Performance
Historical ComparisonAbout WALD Waldencast plc
Waldencast PLC is a beauty and wellness operating platform. The company is organized into two reportable segments namely Obagi Skincare and Milk Makeup. The company generates the majority of its revenue from the Obagi Medical segment. The Obagi Medical segment is engaged in developing, marketing, and selling skin health products. The Milk Makeup segment includes developing, marketing, and selling cosmetics, skincare, and other beauty products. Geographically the company generates the majority of its revenue from North America region.
About FATE Fate Therapeutics Inc.
Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. The company is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.